CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, (NASDAQ: IDRA) a biotechnology company developing Toll-like receptor candidates for the treatment of autoimmune diseases and for use as vaccine adjuvants, today announced that members of the management team will be presenting at the Rodman & Renshaw Annual Global Investment Conference taking place at the Waldorf Astoria in New York City. The presentation will be made in the in North Foyer on Monday, September 10, from 11:15 to 11:40 AM.
